Latest Post

December 28, 2020

Particles in Injectable Drugs

A parenteral drug product contaminated by particles is a potential health threat. In the bloodstream, particles can cause serious issues, such as capillary occlusion and immunogenic responses. In most cases, the observation of particles in a drug product leads to a recall.
Lynn Yao

Lynn Yao

Manager, Scientific Affairs, CN

Categories

Search the Blog

Archive

{1}

{2}
{3}

{4}

  • Previous Posts
    SmartDose Platform

    April 26, 2019

    Overcoming Challenges Associated with Biologic Drug Formulation and Development

    Victoria Morgan

    Victoria Morgan

    Director, Segment Marketing, Global Biologics

    SmartDose, Elastomers, Seals and Syringe plungers

    September 11, 2018

    Supporting Patient Safety – Contribution By Drug Containment Solutions

    Heike Kofler

    Heike Kofler, Ph.D.

    Manager, Technical Customer Support

    Envision Verification Process

    July 16, 2018

    Three Questions to Ask to Improve Your Injectable Drug Packaging Process

    Bill Matakas

    Bill Matakas

    Senior Director, Product Management & Marketing Operations

    Daikyo Crystal Zentih Leur Lock Syringe

    May 01, 2018

    Addressing the Complexities of Ophthalmic Drug Delivery

    Susan Dounce

    Susan Dounce

    Principal SME, Prefilled Syringes, Crystal Zenith, Combination Products

    Vial Adapters

    January 22, 2018

    Use of Vial Adapters Can Reduce Drug Overfill

    Fabrice Berthelot

    Fabrice Berthelot

    Manager, Sales, Administration systems

    SmartDose Gen II and Gen II

    November 06, 2017

    West Announces New Extensions of the SmartDose® Drug Delivery Platform

    Deirdre Swinden

    Deirdre Swinden

    Director, Global Marketing Communications

    Educational series

    October 10, 2017

    West Educational Series – Managing Risk in Injectable Drugs

    Page McAndrew

    Page McAndrew

    Director, Scientific Communications, Scientific Affairs & Technical Services

    Load more